Beranda › Neuroblastoma › Massachusetts › Boston
Uji klinis Neuroblastoma di Boston, MA
13 studi untuk Neuroblastoma mencari peserta di lokasi sekitar Boston (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
Menerima pesertaFase 3
- Massachusetts General Hospital Cancer Center, Boston
- Dana-Farber Cancer Institute, Boston
MCT for the Harvard/UCSF ROBIN Center
Menerima peserta
- Brigham and Women's Hospital, Boston
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
Menerima pesertaFase 1/2
- Dana-Farber Cancer Institute ( Site 1013), Boston
B7-H3.CD28Z.CART in Solid Tumors
Menerima pesertaFase 1
- Dana Farber Cancer Institite, Boston
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
Menerima pesertaFase 3
- Massachusetts General Hospital Cancer Center, Boston
- Dana-Farber Cancer Institute, Boston
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Menerima pesertaFase 1/2
- Dana-Farber Cancer Institute, Boston
SPEARHEAD-3 Pediatric Study
Menerima pesertaFase 1/2
- Dana Farber Cancer Institute, Boston
PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
Menerima pesertaFase 1/2
- Boston Children's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial
Menerima pesertaFase 2
- Boston Children's Hospital, Dana-Farber Cancer Institute., Boston
Feasibility Study of Prolonged Administration of Naxitamab, Irinotecan, and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma
Menerima pesertaFase 1
- Boston Children's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
Neuroblastoma Biology Study
Menerima pesertaStudi observasional
- Children's Hospital Boston, Boston
Resource Intervention to Support Equity (RISE) in High-Risk Neuroblastoma
Menerima peserta
- Dana-Farber Cancer Institute, Boston
Study of hALK.CAR T Cells for Patients With Relapsed/Refractory High-risk Neuroblastoma
Menerima pesertaFase 1/2
- Boston Children's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
Uji klinis Neuroblastoma di kota lain
- Washington, DC11 studi
- New York City, NY10 studi
- Dallas, TX9 studi
- Memphis, TN9 studi
- Philadelphia, PA9 studi
- St. Louis, MO9 studi
- Aurora, CO8 studi
- Hartford, CT8 studi
- Minneapolis, MN8 studi
- Birmingham, AL8 studi
- Atlanta, GA7 studi
- San Francisco, CA7 studi
Studi lain di Boston
- Kanker Payudara111 studi
- Kanker Paru Non-Sel Kecil90 studi
- Kanker (semua jenis)86 studi
- Kanker Kolorektal63 studi
- Kanker Metastatik63 studi
- Kanker Paru62 studi
- Kanker Ovarium61 studi
- Kanker Prostat59 studi
- Depresi52 studi
- Kanker Endometrium50 studi
- Gagal Jantung44 studi
- Leukemia Mieloid Akut44 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.